Package Leaflet: Information for the User
Alzil plus 5 mg/10 mg film-coated tablets
Alzil plus 10 mg/10 mg film-coated tablets
Alzil plus 20 mg/10 mg film-coated tablets
Alzil plus 40 mg/10 mg film-coated tablets
rosuvastatin / ezetimibe
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
This medicine contains two different active substances in one film-coated tablet. One of the active substances is rosuvastatin calcium, which belongs to a group of medicines called statins, the other active substance is ezetimibe.
Alzil plus is a medicine used to reduce the levels of total cholesterol, "bad" cholesterol (LDL cholesterol) and substances called triglycerides that circulate in the blood. Additionally, Alzil plus increases the levels of "good" cholesterol (HDL cholesterol). This medicine works by reducing cholesterol in two ways: it reduces the cholesterol absorbed in the digestive tract, as well as the cholesterol produced by the body itself.
For most people, high cholesterol levels do not affect how they feel, as they do not produce any symptoms. However, if left untreated, fatty deposits can build up in the walls of blood vessels and narrow them.
Sometimes, these narrowed blood vessels can become blocked, cutting off the blood supply to the heart or brain, which can cause a heart attack or stroke. By reducing cholesterol levels, you can reduce your risk of having a heart attack, stroke, or other health problems related to it.
This medicine is used in patients who cannot control their cholesterol levels with diet alone. While taking this medicine, you should continue to follow a cholesterol-reducing diet.
Your doctor may prescribe Alzil plus if you are already taking rosuvastatin and ezetimibe at the same dose level.
Alzil plus is used if you have:
This medicine does not help you lose weight.
Do not take Alzil plus if:
Additionally, do not take Rosuvastatin 40 mg (the highest dose):
If you are in any of the above situations (or are unsure), please consult your doctor again.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Alzil plus if:
If you are in any of these situations mentioned above (or are unsure): consult your doctor or pharmacist before starting to take any dose of Alzil plus.
In a small number of people, statins can affect the liver. This is detected by a simple blood test that detects increased levels of liver enzymes in the blood. For this reason, your doctor will normally perform blood tests (liver function tests) during treatment with this medicine. It is essential that you go to the doctor for these tests.
While taking this medicine, your doctor will closely monitor you if you have diabetes or are at risk of developing diabetes. You are likely to be at risk of developing diabetes if you have high levels of sugar and fats in your blood, are overweight, and have high blood pressure.
Be careful with Alzil plus:
Severe skin reactions, including Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported with Alzil plus treatment. Stop using Alzil plus and seek medical attention immediately if you notice any of the symptoms described in section 4.
Children and adolescents
Alzil plus is not recommended for use in children and adolescents under 18 years of age.
Other medicines and Alzil plus
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Inform your doctor if you are taking any of the following medicines:
If you go to the hospital or receive treatment for another illness, tell the medical staff that you are taking Alzil plus.
Alzil plus with alcohol
Do not take Alzil plus 40 mg/10 mg (the highest dose) if you regularly drink large amounts of alcohol.
Pregnancy and breastfeeding
Do not take Alzil plus if you are pregnant, think you may be pregnant, or plan to become pregnant. If you become pregnant while taking this medicine, stop taking it immediately and inform your doctor. Women must use contraceptive methods during treatment with Alzil plus.
Do not take Alzil plus if you are breastfeeding, as it is not known whether the medicine passes into breast milk.
Driving and using machines
This medicine is not expected to affect your ability to drive or use machines. However, some people may feel dizzy after taking Alzil plus. If you feel dizzy, consult your doctor before attempting to drive or use machines.
Alzil plus contains lactose
Alzil plus film-coated tablets contain a sugar called lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Alzil plus contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially, "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
You should continue to follow a cholesterol-reducing diet while taking Alzil plus.
The recommended daily dose for adults is one tablet of the indicated dose.
Take Alzil plus once a day.
You can take it at any time of the day, with or without food. Swallow each tablet whole with water.
Take your medicine at the same time each day.
Alzil plus is not suitable for starting treatment. The start of treatment or dose adjustments, if necessary, should only be done by taking the active substances separately, and once the appropriate doses are adjusted, it is possible to switch to the appropriate dose of Alzil plus.
The maximum daily dose of rosuvastatin is 40 mg. This dose is only for patients with high cholesterol levels and a high risk of having a heart attack or stroke, whose cholesterol levels do not decrease sufficiently with 20 mg.
If your doctor has prescribed Alzil plus with other cholesterol-lowering medicines that contain the active substance colestyramine or another medicine that contains a bile acid sequestrant, you should take Alzil plus at least 2 hours before or 4 hours after taking these medicines.
Regular cholesterol level checks
It is essential that you visit your doctor regularly to have your cholesterol levels checked, to ensure that your cholesterol levels have normalized and are maintained at appropriate levels.
If you take more Alzil plus than you should
Contact your doctor or the nearest hospital emergency department immediately, as you may need medical attention.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Alzil plus
Do not worry, omit the missed dose and take the next scheduled dose at the planned time. Do not take a double dose to make up for missed doses.
If you stop taking Alzil plus
Consult your doctor if you want to stop taking Alzil plus. Your cholesterol levels may increase again if you stop taking Alzil plus.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
It is essential that you know what these adverse effects can be.
Stop taking Alzil plus and seek immediate medical attentionif you experience any of the following allergic reactions:
Also, stop taking Alzil plus and consult your doctor immediately:
The following terms are used to describe how frequently adverse effects have been reported:
Very common adverse effects (may affect more than 1 in 10 people)
Common adverse effects (may affect up to 1 in 10 people)
Uncommon adverse effects (may affect up to 1 in 100 people)
Rare adverse effects (may affect up to 1 in 1,000 people)
Very rare adverse effects (may affect up to 1 in 10,000 people, including isolated cases)
Common adverse effects (may affect up to 1 in 10 people)
Uncommon adverse effects (may affect up to 1 in 100 people)
Rare adverse effects (may affect up to 1 in 1,000 people)
Very rare adverse effects (may affect up to 1 in 10,000 people)
Jaundice (yellowing of the skin and eyes); liver inflammation (hepatitis); blood traces in urine; nerve damage in the legs and arms (such as numbness); memory loss; increased breast size in men (gynecomastia).
Frequency not known (cannot be estimated from available data)
Difficulty breathing; edema (swelling); sleep disturbances, including insomnia and nightmares; sexual dysfunction; depression; respiratory problems, including persistent cough and/or difficulty breathing or fever; tendon injuries; constant muscle weakness; gallstones or gallbladder inflammation (which can cause abdominal pain, nausea, vomiting); severe myasthenia (a disease that causes generalized muscle weakness that, in some cases, affects the muscles used for breathing); ocular myasthenia (a disease that causes weakness of the eye muscles).
Consult your doctor if you experience weakness in the arms or legs that worsens after periods of activity, double vision, or drooping eyelids, difficulty swallowing, or difficulty breathing.
Reporting adverse effects:
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report it directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep in the original packaging to protect it from light and moisture. This medicine does not require any special storage temperature.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the box or packaging after "EXP". The expiration date is the last day of the month indicated.
Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines you no longer need at the pharmacy's SIGRE point. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Alzil plus
The active ingredients are rosuvastatin (as rosuvastatin calcium) and ezetimibe.
Alzil plus 5 mg/10 mg:
Each film-coated tablet contains 5.20 mg of rosuvastatin calcium (equivalent to 5 mg of rosuvastatin) and 10 mg of ezetimibe.
Alzil plus 10 mg/10 mg:
Each film-coated tablet contains 10.40 mg of rosuvastatin calcium (equivalent to 10 mg of rosuvastatin) and 10 mg of ezetimibe.
Alzil plus 20 mg/10 mg:
Each film-coated tablet contains 20.80 mg of rosuvastatin calcium (equivalent to 20 mg of rosuvastatin) and 10 mg of ezetimibe.
Alzil plus 40 mg/10 mg:
Each film-coated tablet contains 41.60 mg of rosuvastatin calcium (equivalent to 40 mg of rosuvastatin) and 10 mg of ezetimibe.
Tablet – Core (same for all doses):Microcrystalline cellulose (E460); Anhydrous colloidal silica (E-551); Magnesium stearate (E-572); Povidone (E-1201); Sodium croscarmellose (E-468); Sodium lauryl sulfate (E-487); Lactose monohydrate; Hypromellose (E-464).
Coating:
Opadry Yellow (5mg/10mg):Hypromellose (E-464); Titanium dioxide (E-171); Macrogol (E-1521); Yellow iron oxide (E-172); Talc (E-553b); Red iron oxide (E-172).
Opadry Beige (10mg/10mg):Hypromellose (E-464); Titanium dioxide (E-171); Macrogol (E-1521); Yellow iron oxide (E-172); Talc (E-553b).
Vivacoat Yellow (20mg/10mg):Hypromellose (E-464); Titanium dioxide (E-171); Macrogol (E-1521); Yellow iron oxide (E-172); Talc (E-553b).
Opadry White (40mg/10mg):Lactose monohydrate; Hypromellose (E-464); Titanium dioxide (E-171); Macrogol (E-1521).
Appearance of the product and package contents
Alzil plus 5 mg/10 mg film-coated tablets are light yellow, round, biconvex tablets with a diameter of approximately 10 mm and marked "EL 5" on one side.
Alzil plus 10 mg/10 mg film-coated tablets are beige, round, biconvex tablets with a diameter of approximately 10 mm and marked "EL 4" on one side.
Alzil plus 20 mg/10 mg film-coated tablets are yellow, round, biconvex tablets with a diameter of approximately 10 mm and marked "EL 3" on one side.
Alzil plus 40 mg/10 mg film-coated tablets are white, round, biconvex tablets with a diameter of approximately 10 mm and marked "EL 2" on one side.
Alzil plus is available in blister packs of 30 and 100 tablets.
Only some package sizes may be marketed.
Marketing authorization holder
Ferrer Internacional, S.A.
Gran Vía Carlos III, 94
08028 – Barcelona (Spain)
Manufacturer
Elpen Pharmaceutical Co. Inc.
Marathonos 95
190 09 Pikermi – Attica (Greece)
or
ELPEN Pharmaceutical Co Inc
Zapani, Block 1048
Keratea, 19001, (Greece)
or
Rontis Hellas Medical and Pharmaceutical Products S.A.
P.O. BOX 3012 Larissa Industrial Area
Larissa, 41500, Greece
This medicine is authorized in the Member States of the European Economic Area under the following names:
Spain:
Alzil plus 5 mg/10 mg film-coated tablets
Alzil plus 10 mg/10 mg film-coated tablets
Alzil plus 20 mg/10 mg film-coated tablets
Alzil plus 40 mg/10 mg film-coated tablets
Portugal:
Rosuvastatina + Ezetimiba Ferrer 5 mg + 10 mg film-coated tablets
Rosuvastatina + Ezetimiba Ferrer 10 mg + 10 mg film-coated tablets
Rosuvastatina + Ezetimiba Ferrer 20 mg + 10 mg film-coated tablets
Rosuvastatina + Ezetimiba Ferrer 40 mg + 10 mg film-coated tablets
Date of the last revision of this prospectus:April 2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of ALZIL PLUS 20 MG/10 MG FILM-COATED TABLETS in October, 2025 is around 18.44 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.